NCT06442748 2026-02-13
LIBRA
Tata Memorial Centre
Phase 3 Recruiting
Clinical Trials
5 trialsNCT02962414 2026-02-03
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Novartis
Phase 3 Active not recruiting
NCT05897658 2024-10-23
LeviTaTe Pilot
Hamilton Health Sciences Corporation
Phase 3 Not yet recruiting
NCT02544750 2022-07-14
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Phase 3 Completed
NCT01601314 2018-01-17
MAGNA
Fundacion Clinic per a la Recerca Biomédica
Phase 3 Completed